Rhinometry Systems Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Rhinometry Systems Market is segmented By Product Type (Acoustic Rhinometry, Optical Rhinometry, Impedance Rhinometry), By Application (Allergy Diagnosis, Nasal Surgery, Respiratory Disease Diagnosis, Others), By End-user (Hospitals, ENT Clinics, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.

Market Overview

Global Rhinometry Systems Market reached US$ YY billion in 2022 and is expected to reach US$ YY  million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.

Rhinomanometry, which measures nasal pressure and airflow during breathing, is accepted as the standard technique for measuring nasal airway resistance and assessing the patency of the nose. Acoustic rhinometry uses a reflected sound signal to measure the cross-sectional area and volume of the nasal passage. 

Rhinomanometry is useful to improve patient selection for surgery, distinguish between structural and functional causes of nasal obstruction, diagnose nasal valve collapse, clarify conflicting symptoms and exam findings, use as a medicolegal tool and in nasal allergen challenges.

Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers and Restraints

Rise in the prevalence of allergic rhinitis

The rise in the prevalence of allergic rhinitis is one of the significant key factors that drive the rhinometry systems market during the forecast period. For instance, according to the article published in the National Library of Medicine 2023, the prevalence of allergic rhinitis cases ranged from 1.83 to 9.23% between 2017 and 2022. There was a significant drop of 21.38 to 70.22% between the pre- and post-COVID-19 pandemic. Males were more prevalent in the 6 to 18-year-olds than females. Thus, the above factors help to drive market growth during the forecast period.

Furthermore, the global rhinometry systems market is also driven by various factors like technological advancements in rhinometry, a rise in the prevalence of nasal disorders, a rise in non-invasive diagnostic techniques and others that will drive the market growth during the forecast period.

Market Dynamics: Restraint

High costs associated with rhinometry systems, the initial investment and maintenance costs of rhinometry systems can be substantial, posing a challenge for healthcare facilities, particularly in developing regions. The high costs associated with these systems may limit their adoption, hindering market growth.

Also, lack of skilled professionals the effective use of rhinometry systems requires trained healthcare professionals who can accurately interpret the data obtained from these devices. The shortage of skilled personnel in certain regions may pose a restraint to market growth. Efforts should be made to train and educate healthcare professionals on the usage and interpretation of rhinometry systems. 

Market Segment Analysis

The global rhinometry systems is segmented based on product type, application, end-user and region.

The acoustic rhinometry from the product type segment accounted for approximately 41.2% of the market share 

The acoustic rhinometry from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Acoustic rhinometry is a new technique which evaluates nasal obstruction by analysing reflections of a sound pulse introduced via the nostrils. The technique is rapid, reproducible, non-invasive and requires minimal cooperation from the subject. Unlike rhinomanometry, it does not require airflow. A graph of the nasal cross-sectional area as a function of distance from the nostril is produced, from which several area and volume estimates of the nasal cavity can be derived. 

The role of acoustic rhinometry in diagnosis is quantifying nasal obstruction. This procedure is particularly important with secondary rhinoplasty patients whose complaints include substantial functional problems in addition to aesthetic concerns. 

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to be attributed to well-established healthcare infrastructure, rising prevalence of septal deviation, and technological advancements in rhinometry systems in the region. In terms of revenue.

For instance, in March 2020, GM Instruments stated that an exclusive distribution partnership with BioResearch Associates Inc. This partnership supports the North American market expansion into the dental/dental sleep market with a reputable partner experienced in innovative ENT products.

Alongside our distribution partner, we are implementing a collaborative, interdisciplinary approach to patient care and outcomes with a network of dentists and ENTs. There is a need for healthcare policy financial considerations and if 20% of the patients undergoing unnecessary septal surgical intervention were identified pre-operatively then potentially 12 million pounds could be saved with an additional significant reduction in the number of NHS hospital bed days wasted. 

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the healthcare industry, including the rhinometry systems market. The pandemic has highlighted the importance of non-invasive diagnostic techniques, remote monitoring, and telemedicine. Rhinometry systems, with their non-invasive nature and potential for remote patient care, have gained prominence during the pandemic. Competitive Landscape

The major global players in the rhinometry systems market include Happersberger otopront GmbH , ECLERIS, GM Instruments, Homoth Medizinelektronik GmbH & Co, Recorders and Medicare, ATMOS MedizinTechnik GmbH , Sensonics International  , Piston Medical, BioRESEARCH Associates, Inc, HealthManagement and among others.

Key Developments

• In June 2022, Vivos Therapeutics signed an exclusive distribution agreement with GM Instruments for the NR6 Rhinomanometer, an FDA-approved device used to measure nasal airway resistance, for treating dentofacial abnormalities and OSA in adults.

Why Purchase the Report?

• To visualize the global rhinometry systems market segmentation-based product type, application,  end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of rhinometry systems market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global rhinometry systems market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies